Abstract: The present technology may include an error correction code engine configured to generate a parity bit and syndrome information by performing an operation according to operation source data, and a data processing circuit configured to simultaneously output the parity bit and first delay data, which is generated by delaying input data by a first time according to a write operation, simultaneously output the syndrome information and second delay data, which is generated by delaying input data by a second time according to a read operation, and to share substantially the same signal path in generating the first delay data and in generating the second delay data.

Abstract: The present technology may include a first storage circuit connected to a plurality of memory banks, an error correction circuit, a read path including a plurality of sub-read paths connected between the plurality of memory banks and the error correction circuit, and a control circuit configured to control data output from the plurality of memory banks to be simultaneously stored in the first storage circuit by deactivating the read path during a first sub-test section, and to control the data stored in the first storage circuit to be sequentially transmitted to the error correction circuit by sequentially activating the plurality of sub-read paths during a second sub-test section.

Abstract: Disclosed herein are an adhesive protective film, an optical member including the same, and an optical display including the same. An adhesive protective film is formed of a composition including a (meth)acrylic binder derived from a monomer mixture including: an alkyl group-containing (meth)acrylic monomer; and at least one selected from among a hydroxyl group-containing (meth)acrylic monomer, a carboxyl group-containing (meth)acrylic monomer, and a polysiloxane (meth)acrylate, the adhesive protective film having an initial peel strength of about 100 gf/inch or less and a peel strength decrease rate of about 50% or less, as calculated according to Equation 1.

Abstract: A display device includes a substrate including a plurality of emission areas respectively corresponding to a plurality of subpixels for displaying an image, a plurality of light emitting elements respectively located in the plurality of emission areas of a first surface of the substrate and respectively corresponding to the plurality of subpixels, a first planarization layer on the first surface of the substrate and covering the plurality of light emitting elements, and an array layer on the first planarization layer.

Abstract: A method for manufacturing a flavor capsule of tobacco according to an embodiment of the present disclosure may comprise: a membrane manufacturing step for manufacturing a membrane of a flavor capsule by a membrane manufacturing part that manufactures a membrane; a capsule manufacturing step for manufacturing the flavor capsule using an apparatus for manufacturing a capsule with the membrane manufactured during the membrane manufacturing step and a flavored liquid to be held in the membrane; and a hardening step for hardening the flavor capsule.

Abstract: A display device includes a scan write line, a PWM emission line, a PAM emission line, a sweep signal line, a first data line, a second data line, and a subpixel connected thereto, and including a light emitting element, a first pixel driver to supply a control current to a node according to the first data voltage in response to the PWM emission signal, a second pixel driver to generate a driving current according to the second data voltage in response to the PWM emission signal, and a third pixel driver to supply the driving current to the light emitting element according to the PAM emission signal and a voltage of the node, wherein the PWM emission signal includes a plurality of PWM pulses, the PAM emission signal includes a plurality of PAM pulses, and a number of the PWM pulses is greater than a number of the PAM pulses.

Abstract: A steroid sulfatase inhibitor provided by the present invention is a safe substance without toxicity and adverse effects, has inhibitory activity against various viruses, and thus is capable of effectively preventing, ameliorating, or treating viral infections or diseases caused by viral infections.

Abstract: A display device includes connection lines, pulse amplitude modulation (PAM) data lines configured to receive pulse width modulation (PWM) data voltages, PWM data lines configured to receive the PWM data voltages, a first connection control line configured to receive a first connection control signal, a second connection control line configured to receive a second connection control signal, subpixels connected to the PWM data lines and the PAM data lines, and a first demultiplexer (demux) unit configured to connect the connection lines to the PAM data lines or to the PWM data lines according to the first connection control signal and the second connection control signal.

Abstract: A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.

Abstract: The present invention relates to a composition for enhancing the sensitivity to a pulmonary fibrosis inhibitor, the composition comprising, as an active ingredient, stearic acid, a salt of the stearic acid or a prodrug of the stearic acid. In addition, the present invention relates to a pharmaceutical composition for preventing or treating pulmonary fibrosis, the composition comprising, as active ingredients: stearic acid, a salt of the stearic acid or a prodrug of the stearic acid; and a pulmonary fibrosis inhibitor. According to the present invention, a more excellent treatment effect may be induced by the co-administration of a conventional pulmonary fibrosis inhibitor and stearic acid, and by using stearic acid, the sensitivity to the conventional pulmonary fibrosis inhibitor may be enhanced, and an excellent treatment effect is expected to be achieved even for pulmonary fibrosis showing resistance to the conventional pulmonary fibrosis inhibitor.

Abstract: An exercise system comprises a stationary exercise apparatus including support arms, exercise parts, and a frame, at least one electromyograph configured to be worn on at least one body portion of a user, the electromyograph including an electromyogram sensor and a motion sensor, and a smart device configured to obtain a posture according to the detected motion, elect at least one exercise part corresponding to the posture from among the exercise parts, determine a target exercise part among the at least one exercise part elected, obtain a muscle strength by analyzing the detected electromyogram, record a muscle strength enhancement history in association with a use history of the determined target exercise part, and output the recorded muscle strength enhancement history and the use history.

Abstract: The present invention relates to an impedance measuring device obtaining impedance of portions of an object corresponding to two sensing electrodes by detecting, through the two sensing electrodes, an electrical variation shown on the object as an electrical signal is applied. A detector amplifying each of signals detected through the two sensing electrodes and then differential-operating the amplified signals to generate a signal for obtaining impedance is subjected to a calibration process for adjusting the gain of the amplifiers to reduce in-phase noise added due to an imbalance between the sensing electrodes.

Abstract: The present invention relates to an impedance measuring device obtaining impedance of portions of an object corresponding to two sensing electrodes by detecting, through the two sensing electrodes, an electrical variation shown on the object as an electrical signal is applied. A detector amplifying each of signals detected through the two sensing electrodes and then differential-operating the amplified signals to generate a signal for obtaining impedance is subjected to a calibration process for adjusting the gain of the amplifiers to reduce in-phase noise added due to an imbalance between the sensing electrodes.

Abstract: The invention provides novel substituted heterocyclic compounds represented by Formula I and Formula II, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans.

Abstract: The invention provides novel substituted pyridopyrimidines represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3? OH kinase family (PI3K) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders.

Abstract: The invention provides novel substituted heterocyclic compounds represented by Formula I and Formula II, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans.

Abstract: According to an embodiment of the present disclosure, a biosignal measuring device comprises two channels respectively detecting bio-potential signals from a human body through two electrodes, a biosignal extracting unit including two detecting means respectively amplifying the bio-potential signals through amplifiers, respectively, differentially operating the amplified bio-potential signals through a differential operator, and selectively adopting respective output signals of the two detecting means to obtain a biosignal, and an impedance correcting means adjusting the amplitude of the amplifiers of the two detecting means so that the power of a common mode noise signal caused by an impedance imbalance between the channels and included in the obtained biosignal is reduced to suppress the common mode noise signal.

Abstract: The invention provides novel substituted pyridopyrimidines represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3? OH kinase family (PI3K) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders.

Abstract: The invention provides novel substituted pyridopyrimidines represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3? OH kinase family (PI3K) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders.

Abstract: The invention provides novel substituted pyridopyrimidines represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3? OH kinase family (PI3K) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders.